+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "GABA Receptor Agonist"

GABA Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

GABA Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Fragile X Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Fragile X Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 136 Pages
  • Global
From
Tardive Dyskinesia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Tardive Dyskinesia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
GABA Receptor Agonist Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Thumbnail Image

GABA Receptor Agonist Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • August 2024
  • 104 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The GABA Receptor Agonist market is a subset of the Central Nervous System Drugs market. GABA Receptor Agonists are drugs that activate the GABA receptor, a type of neurotransmitter receptor found in the brain. These drugs are used to treat a variety of neurological disorders, including anxiety, insomnia, and epilepsy. GABA Receptor Agonists are typically administered orally, intravenously, or intramuscularly. The GABA Receptor Agonist market is highly competitive, with a number of large pharmaceutical companies vying for market share. Companies in this market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Additionally, there are a number of smaller companies that specialize in the development and manufacture of GABA Receptor Agonists. Show Less Read more